Cargando...
Pazopanib in the treatment of advanced renal cell carcinoma
Pazopanib is an orally available multitargeted tyrosine kinase inhibitor (a class of targeted therapies) that inhibits tumor angiogenesis and cell proliferation. The safety and efficacy of pazopanib (noninferior to sunitinib for progression-free survival) in patients with advanced or metastatic rena...
Guardado en:
| Publicado en: | Ther Adv Urol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707425/ https://ncbi.nlm.nih.gov/pubmed/26834841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215614236 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|